-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Hebei Guangxiang Secures Its First Patent Certificate
Category:
发布时间：2019-12-03
【概要描述】
Recently, good news came from the National Intellectual Property Administration: the technological innovation achievement “Continuous Cooling Crystallization Apparatus for Sodium Theophylline Salt,” submitted by the Group Company and Hebei Guangxiang Pharmaceutical Co., Ltd., has been granted a utility model patent certificate. According to reports, this marks the first patent certificate ever obtained by Hebei Guangxiang Pharmaceutical.
Recently, good news came from the National Intellectual Property Administration: the innovative technological achievement of the “Continuous Cooling Crystallization Apparatus for Sodium Theophylline Salt,” submitted by the Group Company and Hebei Guangxiang Pharmaceutical Co., Ltd., has been granted a utility model patent certificate. According to reports, this marks the first patent certificate ever obtained by Hebei Guangxiang Pharmaceutical.
According to the R&D team, this project leverages innovative and cutting-edge technologies to design a novel utility model device that significantly enhances the production efficiency of sodium theophylline, features a compact layout to minimize land use, and produces crystals with larger, more uniform particle sizes. The process control system is implemented on a DCS platform, enabling fully automated centralized control of process parameters to ensure process stability, increase the level of automation in production, and reduce labor intensity.
In recent years, the Group has placed great emphasis on technological innovation, continuously attracting high-caliber talent, increasing investment in research and development, and prioritizing intellectual property protection. To date, the company has filed more than 110 patent applications. These patent achievements have built up momentum for the company’s future growth, enhanced the technological sophistication of its products, and provided robust scientific and technological support for its sustained development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091